About: http://webisa.webdatacommons.org/53500537

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	For accelerated approval, there must be evidence that the product has an effect on an endpoint that is reasonably likely to predict clinical benefit (i.e. an effect on a clinical endpoint other than survival or irreversible morbidity).
http://www.w3.org/ns/prov#wasQuotedFrom	cureduchenne.com